Clinical Trials in Fukushima, Japan
Locations / Fukushima, Japan
Delta Trials records 496 clinical trials conducted in Fukushima, Japan, making it a notable site of clinical research activity. These trials across 383 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 25 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Fukushima has changed over time.
496
Total Trials
383
Conditions
25
Terminated since 2020
Browse by condition (383 total)
- Breast cancer 14 trialsAll Breast cancer trials
- Non-small cell lung cancer 14 trialsAll Non-small cell lung cancer trials
- Diabetes mellitus, type 2 10 trialsAll Diabetes mellitus, type 2 trials
- Asthma 9 trialsAll Asthma trials
- Rheumatoid arthritis 9 trialsAll Rheumatoid arthritis trials
- Breast neoplasms 8 trialsAll Breast neoplasms trials
- Gastric cancer 7 trialsAll Gastric cancer trials
- Macular degeneration 7 trialsAll Macular degeneration trials
- Major depressive disorder 7 trialsAll Major depressive disorder trials
- All Pulmonary disease, chronic obstructive trials
- Diffuse large B-cell lymphoma 6 trialsAll Diffuse large B-cell lymphoma trials
- Triple negative breast cancer 6 trialsAll Triple negative breast cancer trials
- All Attention deficit hyperactivity disorder trials
- Ulcerative colitis 5 trialsAll Ulcerative colitis trials
- Multiple myeloma 5 trialsAll Multiple myeloma trials
- Carcinoma, non-small-cell lung 5 trialsAll Carcinoma, non-small-cell lung trials
- Leukemia, myeloid, acute 5 trialsAll Leukemia, myeloid, acute trials
- Diabetes 5 trialsAll Diabetes trials
- Endometrial cancer 5 trialsAll Endometrial cancer trials
- Acute myeloid leukemia 5 trialsAll Acute myeloid leukemia trials